18 participants
PANFIRE-3 Trial: Assessing Safety and Efficacy of Irreversible Electroporation (IRE) + Nivolumab + CpG for Metastatic Pancreatic Cancer
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2022-12-20
- Start Date:
- 2020-09-01
- Completion:
- 2023-04-01
Conditions
- Pancreatic Cancer
- Metastatic Pancreatic Cancer
Interventions
- DEVICE
- DRUG
No Results Yet